期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
经内镜下逆行胰胆管造影置入支架治疗恶性胆管梗阻的临床研究 被引量:17
1
作者 沈建伟 张立明 贾晓伟 《中国内镜杂志》 CSCD 北大核心 2013年第2期180-183,共4页
目的探讨内镜下逆行胰胆管造影(ERCP)置入支架治疗恶性胆管梗阻的临床效果。方法回顾性分析2008年8月~2011年2月该院收治的60例恶性胆管梗阻患者的临床资料,60例患者按治疗方式分为胆管支架置入组(支架组,32例)和外科姑息手术组(常规组... 目的探讨内镜下逆行胰胆管造影(ERCP)置入支架治疗恶性胆管梗阻的临床效果。方法回顾性分析2008年8月~2011年2月该院收治的60例恶性胆管梗阻患者的临床资料,60例患者按治疗方式分为胆管支架置入组(支架组,32例)和外科姑息手术组(常规组,28例),常规组患者给予常规外科姑息手术治疗,支架组患者给予经ERCP胆管支架置入术治疗。检测两组患者术前及术后1周肝功能水平,并观察并发症发生情况,随访观察患者生存时间。结果支架组均成功完成支架置入治疗,成功率为100%。手术治疗后,两组肝功能均明显改善,肝功能(TB、ALT、AST、ALP、GGT)水平与术前比较均显著降低,相比较差异均有显著性(均P<0.05);且术后支架组肝功能(TB、ALT、AST、ALP、GGT)水平与对照组比较显著降低,相比较差异均有显著性(均P<0.05);支架组术后并发症发生率为15.6%,常规组为50.0%,相比较差异有显著性(P<0.05);两组术后生存率和平均生存时间比较差异均无显著性(均P>0.05)。结论经ERCP下置入支架优于传统手术,是治疗恶性胆管梗阻的一种较好的方法,手术成功率高,并发症少,值得临床应用。 展开更多
关键词 内镜 ERCP 恶性胆管梗阻 胆管支架 外科姑息手术
下载PDF
内镜下胆管支架置入术治疗31例恶性胆管梗阻患者的疗效分析 被引量:13
2
作者 蒋雨卉 张俊文 《重庆医学》 CAS CSCD 北大核心 2010年第23期3233-3235,共3页
目的探讨分析经内镜胆管支架置入术治疗恶性胆管梗阻的疗效及其与外科姑息手术的对比。方法回顾性对比31例行胆管支架置入术及29例行外科姑息手术治疗的恶性胆管梗阻患者资料。结果经内镜胆管支架置入术成功率为93.55%,能有效退黄和保... 目的探讨分析经内镜胆管支架置入术治疗恶性胆管梗阻的疗效及其与外科姑息手术的对比。方法回顾性对比31例行胆管支架置入术及29例行外科姑息手术治疗的恶性胆管梗阻患者资料。结果经内镜胆管支架置入术成功率为93.55%,能有效退黄和保护肝功能,术后患者近期并发症发生率为9.68%,与外科组的17.24%相比差异无统计学意义(P>0.05),支架组术后住院时间中位数为5 d,短于外科组的13 d。支架组术后胆道平均通畅时间为154.95 d,平均生存时间182.06d,与外科组的223.37 d、239.37 d相比差异无统计学意义(P>0.05)。结论胆管支架置入术安全可行,对晚期恶性胆管梗阻有较好疗效,其效果不逊于外科姑息手术,是治疗恶性胆管梗阻的有效方法之一。 展开更多
关键词 内镜 恶性胆管梗阻 胆管支架 外科姑息手术
下载PDF
Current role of palliative interventions in advanced pancreatic cancer 被引量:4
3
作者 Chelsey C Ciambella Rachel E Beard Thomas J Miner 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2018年第7期75-83,共9页
Pancreatic adenocarcinoma is the third leading cause of cancer death in the United States. Unfortunately, at diagnosis, most patients are not candidates for curative resection. Surgical palliation, a procedure perform... Pancreatic adenocarcinoma is the third leading cause of cancer death in the United States. Unfortunately, at diagnosis, most patients are not candidates for curative resection. Surgical palliation, a procedure performed with the intention of relieving symptoms or improving quality of life, comes to the forefront of management. This article reviews the palliative management of unresectable pancreatic cancer, including obstructive jaundice, duodenal obstruction and pain control with celiac plexus block. Although surgical bypasses for both biliary and duodenal obstructions usually achieve good technical success, they result in considerable perioperative morbidity and mortality, even when performed laparoscopically. The effectiveness of selfexpanding metal stents for biliary drainage is excellent with low morbidity. Surgical gastrojejunostomy for duodenal obstruction appears to be best for patients with a life expectancy of greater than 2 mo while endoscopic stenting has been shown to be feasible with good symptom relief in those with a shorter life expectancy. Regardless of the palliative procedure performed, all physicians involved must be adequately trained in end of life management to ensure the best possible care for patients. 展开更多
关键词 surgical palliation Duodenal obstruction Hepatojejunostomy GASTROJEJUNOSTOMY Endoscopic STENTING Malignant ascites CELIAC block palliatIVE triangle Pancreatic cancer Obstructive JAUNDICE
下载PDF
Surgical palliation of gastric outlet obstruction in advanced malignancy 被引量:2
4
作者 Brittany A Potz Thomas J Miner 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2016年第8期545-555,共11页
Gastric outlet obstruction(GOO) is a common problem associated with advanced malignancies of the upper gastrointestinal tract.Palliative treatment of patients' symptoms who present with GOO is an important aspect ... Gastric outlet obstruction(GOO) is a common problem associated with advanced malignancies of the upper gastrointestinal tract.Palliative treatment of patients' symptoms who present with GOO is an important aspect of their care.Surgical palliation of malignancy is defined as a procedure performed with the intention of relieving symptoms caused by an advanced malignancy or improving quality of life.Palliative treatment for GOO includes operative(open and laparoscopic gastrojejunostomy) and non-operative(endoscopic stenting) options.The performance status and medical condition of the patient,the extent of the cancer,the patients prognosis,the availability of a curative procedure,the natural history of symptoms of the disease(primary and secondary),the durability of the procedure,and the quality of life and life expectancy of the patient should always be considered when choosing treatment for any patient with advanced malignancy.Gastrojejunostomy appears to be associated with better long term symptom relief while stenting appears to be associated with lower immediate procedure related morbidity. 展开更多
关键词 surgical palliation Gastric outlet obstruction ADVANCED MALIGNANCY GASTROJEJUNOSTOMY Endoscopic STENTING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部